Altered Skeletal Muscle Lipase Expression and Activity Contribute to Insulin Resistance in Humans
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Insulin resistance is associated with elevated content of skeletal muscle lipids, including triacylglycerols (TAGs) and diacylglycerols (DAGs). DAGs are by-products of lipolysis consecutive to TAG hydrolysis by adipose triglyceride lipase (ATGL) and are subsequently hydrolyzed by hormone-sensitive lipase (HSL). We hypothesized that an imbalance of ATGL relative to HSL (expression or activity) may contribute to DAG accumulation and insulin resistance. RESEARCH DESIGN AND METHODS: We first measured lipase expression in vastus lateralis biopsies of young lean (n = 9), young obese (n = 9), and obese-matched type 2 diabetic (n = 8) subjects. We next investigated in vitro in human primary myotubes the impact of altered lipase expression/activity on lipid content and insulin signaling. RESULTS: Muscle ATGL protein was negatively associated with whole-body insulin sensitivity in our population (r = −0.55, P = 0.005), whereas muscle HSL protein was reduced in obese subjects. We next showed that adenovirus-mediated ATGL overexpression in human primary myotubes induced DAG and ceramide accumulation. ATGL overexpression reduced insulin-stimulated glycogen synthesis (−30%, P < 0.05) and disrupted insulin signaling at Ser1101 of the insulin receptor substrate-1 and downstream Akt activation at Ser473. These defects were fully rescued by nonselective protein kinase C inhibition or concomitant HSL overexpression to restore a proper lipolytic balance. We show that selective HSL inhibition induces DAG accumulation and insulin resistance. CONCLUSIONS: Altogether, the data indicate that altered ATGL and HSL expression in skeletal muscle could promote DAG accumulation and disrupt insulin signaling and action. Targeting skeletal muscle lipases may constitute an interesting strategy to improve insulin sensitivity in obesity and type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![FIG. 2. ATGL overexpression increases TAG hydrolysis in myotubes. A: Quantitative bar graph of ATGL protein during adenovirus-mediated ATGL overexpression vs. GFP control (n = 4). Insets are showing representative blots of two independent experiments. TAG hydrolase activity (B) and DAG hydrolase activity (C) were measured in control myotubes (GFP) and myotubes overexpressing ATGL (n = 4). Pulse-chase studies using [1-14C]oleate were performed to determine the kinetics of the different lipid pools in response to ATGL overexpression. The rate of incorporation of radiolabeled oleate into (D) TAG, (E) DAG, and (F) FFA was determined in control myotubes (GFP) and myotubes overexpressing ATGL. *P < 0.05; **P < 0.01 vs. GFP (n = 4).](https://figures.cochat.ai/paper-figures/fce5a71ad9c04195a2a2bcf28eea91b5/altered-skeletal-muscle-lipase-expression-and-activity-contribute-to-insulin-figure-2.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Intermediate products such as diacylglycerols generated during the process of lipogenesis may impair insulin signalling in the liver and peripheral tissues and then lead to insulin resistance.97”
From Dietary sugar consumption and health: umbrella review (2023) · cites this paper as [97]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751 · cited 2×
“prepared by the method of Bligh and Dyer (31) in the presence of non-naturally occurring Cer 14:0, Cer 17:0.”
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“Insulin sensitivity was measured by clamp (26).”
Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride–methanol
Morrison, W. R., & Smith, L. M. (1964) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40190-7 · Cited by 5,985
Watterson, K. R., Bestow, D., Gallagher, J., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2013) · Neurosignals · doi:10.1159/000334144 · Cited by 3,389
Fat Mobilization in Adipose Tissue Is Promoted by Adipose Triglyceride Lipase
Zimmermann, R., Strauss, J. G., Haemmerle, G., Schoiswohl, G., Birner-Gruenberger, R., Riederer, M., Lass, A., Neuberger, G., Eisenhaber, F., Hermetter, A., et al. (2004) · Science · doi:10.1126/science.1100747 · Cited by 2,116
Triglyceride accumulation protects against fatty acid-induced lipotoxicity
Listenberger, L. L., Han, X., Lewis, S. E., Cases, S., Farese, R. V., Ory, D. S., & Schaffer, J. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630588100 · Cited by 2,075 · cited 1×
“and to avoid the intrinsic lipotoxic effect of palmitate (20,21).”
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435 · cited 5×
“A: Representative blots of Ser473 pAkt, total Akt, and GAPDH in the presence (+) or absence (2) of insulin in control myotubes (GFP) and myotubes overexpressing ATGL alone (Ad-ATGL) or in combination with HSL (Ad-ATGL+ Ad-HSL).”
InfluentialItani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390
Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase
Haemmerle, G., Lass, A., Zimmermann, R., Gorkiewicz, G., Meyer, C., Rozman, J., Heldmaier, G., Maier, R., Theussl, C., Eder, S., et al. (2006) · Science · doi:10.1126/science.1123965 · Cited by 1,375 · cited 2×
“ATGL-deficient mice are more insulin sensitive and glucose tolerant despite a threefold increase in TAG content in their skeletal muscle (17).”
Cited by
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294
“The nonselective PKC inhibitor calphostin-C prevents this impairment in insulin signaling, suggesting that PKC activation is required for ATGL-mediated insulin resistance (Badin et al., 2011).”
InfluentialObesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications
Wondmkun, Y. T. (2020) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s275898 · Cited by 706
What causes the insulin resistance underlying obesity?
Hardy, O. T., Czech, M. P., & Corvera, S. (2012) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e3283514e13 · Cited by 563
Insulin Resistance, Obesity and Lipotoxicity
Yazıcı, D., & Sezer, H. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-48382-5_12 · Cited by 499
Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans
Szendroedi, J., Yoshimura, T., Phielix, E., Koliaki, C., Marcucci, M., Zhang, D., Jelenik, T., Müller, J., Herder, C., Nowotny, P., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409229111 · Cited by 415
“Enzymes involved in DAG synthesis (adipose triglyceride lipase) are negatively related to insulin sensitivity (36), whereas enzymes controlling DAG hydrolysis (hormone-sensitive lipase) or conversion to triacylglycerols are decreased in obese humans (36).”
BackgroundDietary sugar consumption and health: umbrella review
Huang, Y., Chen, Z., Chen, B., Li, J., Yuan, X., Li, J., Wang, W., Dai, T., Chen, H., Wang, Y., et al. (2023) · BMJ · doi:10.1136/bmj-2022-071609 · Cited by 348
“97 Subsequently, it may promote ectopic fat deposition in the liver and muscle.”
BackgroundDAG tales: the multiple faces of diacylglycerol—stereochemistry, metabolism, and signaling
Eichmann, T. O., & Lass, A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1982-3 · Cited by 314
“A recent study reported that overexpression of ATGL in cultured myotubes leads to increased DAG and ceramides levels which was found to be associated with impaired insulin signaling [235].”
Role of intramyocelluar lipids in human health
Coen, P. M., & Goodpaster, B. H. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.05.009 · Cited by 252
Lipid modulation of skeletal muscle mass and function
Lipina, C., & Hundal, H. S. (2017) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12144 · Cited by 247
“lean control subjects, as well as reduced muscle HSL expression in obese individuals.(57) In addition, the authors of”
BackgroundThe Regulation of Fat Metabolism during Aerobic Exercise
Muscella, A., Stefàno, E., Lunetti, P., Capobianco, L., & Marsigliante, S. (2020) · Biomolecules · doi:10.3390/biom10121699 · Cited by 237
“The functional importance of ATGL is demonstrated by an increased TG hydrolase activity and decreased TG content in myotubes overexpressing ATGL [219].”
BackgroundBesse-Patin, A., Montastier, E., Vinel, C., Castan-Laurell, I., Louche, K., Dray, C., Daviaud, D., Mir, L., Marques, M.-A., Thalamas, C., et al. (2014) · International Journal of Obesity · doi:10.1038/ijo.2013.158 · Cited by 227
Self-citationMeex, R. C. R., Blaak, E. E., & van Loon, L. J. C. (2019) · Obesity Reviews · doi:10.1111/obr.12862 · Cited by 211
Sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts
Ma, J., Fox, C. S., Jacques, P. F., Speliotes, E. K., Hoffmann, U., Smith, C. E., Saltzman, E., & McKeown, N. M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.032 · Cited by 211
“It also has been hypothesized that the intermediate products, such as diacyglycerols generated when fructose is converted to triglycerides, may trigger insulin resistance [38] and, subsequently, induce fat accumulation in the liver [39].”
BackgroundNatriuretic peptides enhance the oxidative capacity of human skeletal muscle
Engeli, S., Birkenfeld, A. L., Badin, P.-M., Bourlier, V., Louche, K., Viguerie, N., Thalamas, C., Montastier, E., Larrouy, D., Harant, I., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64526 · Cited by 197
Self-citationTargeting fatty acid metabolism to improve glucose metabolism
Stinkens, R., Goossens, G. H., Jocken, J. W. E., & Blaak, E. E. (2015) · Obesity Reviews · doi:10.1111/obr.12298 · Cited by 183
Mechanisms Underlying Metabolic Syndrome-Related Sarcopenia and Possible Therapeutic Measures
Rubio-Ruiz, M. E., Guarner-Lans, V., Pérez-Torres, I., & Soto, M. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030647 · Cited by 165
“The storage of intracellular diacylgyercerols that diminish insulin signaling is increased when the expression of ATGL and HSL is high in skeletal muscle [36].”
BackgroundLipke, K., Kubis-Kubiak, A., & Piwowar, A. (2022) · Cells · doi:10.3390/cells11050844 · Cited by 182
“The development of IR in lipotoxic conditions (human studies and rat NAFLD model) is associated with an increase in PKC activity, suggesting that PKC-activating action of DAG is at least in part involved in the mechanism of FFA-mediated IR induction [43,212,213].”
BackgroundSkeletal muscle energy metabolism in obesity
Mengeste, A. M., Rustan, A. C., & Lund, J. (2021) · Obesity · doi:10.1002/oby.23227 · Cited by 141
Self-citationWatt, M. J., & Hoy, A. J. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00561.2011 · Cited by 142
Li, F., Duan, Y., Li, Y., Tang, Y., Geng, M., Oso, A. O., Kim, S. W., & Yin, Y. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114514004346 · Cited by 154
“It is known that HSL and ACC are rate-limiting enzymes of lipid metabolism(46).”
BackgroundInfluentialLipid metabolism in sarcopenia
Al Saedi, A., Debruin, D. A., Hayes, A., & Hamrick, M. (2022) · Bone · doi:10.1016/j.bone.2022.116539 · Cited by 140
Bosma, M., Kersten, S., Hesselink, M. K. C., & Schrauwen, P. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.11.003 · Cited by 156
“showed an imbalance between ATGL and HSL protein expression and activity in obese diabetics versus lean controls [117], consistent with the studies of Moro et al.”
BackgroundResultInfluentialWu, W., Feng, J., Jiang, D., Zhou, X., Jiang, Q., Cai, M., Wang, X., Shan, T., & Wang, Y. (2017) · Scientific Reports · doi:10.1038/srep41606 · Cited by 117
“At the molecular level, substantial studies have revealed that several genes have considerable impacts on skeletal muscle lipid metabolism, including ATGL (adipose triglyceride lipase) 10–12 , HSL (hormone-sensitive lipase) 13 and AMPK 14–19 .”
Origins of metabolic complications in obesity: adipose tissue and free fatty acid trafficking
Mittendorfer, B. (2011) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32834ad8b6 · Cited by 154
PLIN5 deletion remodels intracellular lipid composition and causes insulin resistance in muscle
Mason, R. R., Mokhtar, R., Matzaris, M., Selathurai, A., Kowalski, G. M., Mokbel, N., Meikle, P. J., Bruce, C. R., & Watt, M. J. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.06.002 · Cited by 115
Molecular modulators of celastrol as the keystones for its diverse pharmacological activities
Ng, S. W., Chan, Y., Chellappan, D. K., Madheswaran, T., Zeeshan, F., Chan, Y. L., Collet, T., Gupta, G., Oliver, B. G. G., Wark, P. A. B., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.051 · Cited by 107
“As for PKC- θ, downregulation of this protein results in a decrease in total and cytosolic diacylglycerol (DAG), which has a positive effect on insulin sensitivity due to the ability of DAG to regulate insulin signalling [85,86].”
BackgroundCoen, P. M., Hames, K. C., Leachman, E. M., DeLany, J. P., Ritov, V. B., Menshikova, E. V., Dubé, J. J., Stefanovic-Racic, M., Toledo, F. G. S., & Goodpaster, B. H. (2013) · Obesity · doi:10.1002/oby.20381 · Cited by 97
“PNPLA2 (ATGL) expression was not altered with obesity in this study, a finding that is congruent with the findings of others (12,40).”
ResultThe role of triglyceride lipases in cancer associated cachexia
Das, S. K., & Höefler, G. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.02.006 · Cited by 98
SIRT1 enhances glucose tolerance by potentiating brown adipose tissue function
Boutant, M., Joffraud, M., Kulkarni, S. S., García-Casarrubios, E., García-Roves, P. M., Ratajczak, J., Fernández-Marcos, P. J., Valverde, A. M., Serrano, M., & Cantó, C. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2014.12.008 · Cited by 93
Promoting longevity by maintaining metabolic and proliferative homeostasis
Wang, L., Karpac, J., & Jasper, H. (2014) · Journal of Experimental Biology · doi:10.1242/jeb.089920 · Cited by 93
“been linked to the dyslipidemia associated with type 2 diabetes and other metabolic syndromes (Shimomura et al., 2000; Schoenborn et al., 2006; Badin et al., 2011).”
BackgroundLaurens, C., Bourlier, V., Mairal, A., Louche, K., Badin, P.-M., Mouisel, E., Montagner, A., Marette, A., Tremblay, A., Weisnagel, J. S., et al. (2016) · Scientific Reports · doi:10.1038/srep38310 · Cited by 93
Self-citationDefective Natriuretic Peptide Receptor Signaling in Skeletal Muscle Links Obesity to Type 2 Diabetes
Coué, M., Badin, P.-M., Vila, I. K., Laurens, C., Louche, K., Marqués, M.-A., Bourlier, V., Mouisel, É., Tavernier, G., Rustan, A. C., et al. (2015) · Diabetes · doi:10.2337/db15-0305 · Cited by 89
“2 mmol/L) were grown in DMEM supplemented with 10% FBS and growth factors (human epidermal growth factor, BSA, dexamethasone, gentamycin, fungizone, and fetuin) as previously described (23,30).”
MethodSelf-citationJocken, J. W. E., Goossens, G. H., Boon, H., Mason, R. R., Essers, Y., Havekes, B., Watt, M. J., van Loon, L. J., & Blaak, E. E. (2013) · Diabetologia · doi:10.1007/s00125-013-2995-9 · Cited by 87
“glucose disposal), at least in part through a PKC-dependent pathway, as has been suggested recently in vitro in human primary myotubes [19].”
BackgroundResultInfluentialMa, J., Jacques, P. F., Meigs, J. B., Fox, C. S., Rogers, G. T., Smith, C. E., Hruby, A., Saltzman, E. J., & McKeown, N. M. (2016) · Journal of Nutrition · doi:10.3945/jn.116.234047 · Cited by 104
“In the process of lipogenesis, sugar may be converted to products such as diacylglycerols that are harmful to insulin signaling (34).”
BackgroundHigh Fat With High Sucrose Diet Leads to Obesity and Induces Myodegeneration
Rasool, S., Geetha, T., Broderick, T. L., & Babu, J. R. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01054 · Cited by 82
“Evidence suggests targeting of skeletal muscle lipases may be an effective approach to overcome resistance for insulin (Badin et al., 2011).”
BackgroundInfluentialDynamics of skeletal muscle lipid pools
Badin, P.-M., Langin, D., & Moro, C. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.08.001 · Cited by 80
Self-citationLouche, K., Badin, P.-M., Montastier, E., Laurens, C., Bourlier, V., de Glisezinski, I., Thalamas, C., Viguerie, N., Langin, D., & Moro, C. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2058 · Cited by 78
“A causal relationship between elevated ATGL and/or reduced HSL activity and insulin resistance was shown in vitro in human primary myotubes (7).”
BackgroundResultInfluentialSelf-citationBadin, P.-M., Vila, I. K., Louche, K., Mairal, A., Marques, M.-A., Bourlier, V., Tavernier, G., Langin, D., & Moro, C. (2013) · Endocrinology · doi:10.1210/en.2012-2029 · Cited by 78
“This is also in line with recent findings showing an increased DAG accumulation and mild insulin resistance in human primary myotubes treated with a selective HSL inhibitor (7).”
BackgroundMethodResultInfluentialSelf-citationThe cause–effect relation of tuberculosis on incidence of diabetes mellitus
Bisht, M. K., Dahiya, P., Ghosh, S., & Mukhopadhyay, S. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1134036 · Cited by 102
“Mtb infection causes dysregulation of lipid metabolism and elevates the levels of circulating free fatty acids which causes ectopic deposition of lipids in organs important for glucose homeostasis like liver and skeletal muscles leading to development of IR (Badin et al., 2011; Oswal et al., 2022).”
BackgroundSkeletal Muscle Triacylglycerol Hydrolysis Does Not Influence Metabolic Complications of Obesity
Sitnick, M. T., Basantani, M. K., Cai, L., Schoiswohl, G., Yazbeck, C. F., Distefano, G., Ritov, V., DeLany, J. P., Schreiber, R., Stolz, D. B., et al. (2013) · Diabetes · doi:10.2337/db13-0500 · Cited by 73
“With regards to IMTG hydrolysis, acutely modulating ATGL or HSL action in cultured human myotubes alters DAGs and disrupts glucose homeostasis and insulin action (33).”
BackgroundKarpac, J., Biteau, B., & Jasper, H. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.004 · Cited by 80
“…in IIS/ Foxo-regulated lipases (such as adipose triglyceride lipase) and lipogenic transcription factors (such as SREBP-1c) have been linked to the dyslipidemia associated with type 2 diabetes and other metabolic syndromes (Badin et al., 2011; Schoenborn et al., 2006; Shimomura et al., 2000).”
BackgroundRen, L., Zhou, X., Huang, X., Wang, C., & Li, Y. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.12.015 · Cited by 77
Insulin Resistance, Obesity, and Lipotoxicity
Yazıcı, D., Demir, S. Ç., & Sezer, H. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_14 · Cited by 97
Pulinilkunnil, T., Kienesberger, P. C., Nagendran, J., Sharma, N., Young, M. E., & Dyck, J. R. B. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.103 · Cited by 79
Skeletal intramyocellular lipid metabolism and insulin resistance
Li, Y., Xu, S., Zhang, X., Yi, Z., & Cichello, S. (2015) · Biophysics Reports · doi:10.1007/s41048-015-0013-0 · Cited by 70
“Increasing DAG accumulation in skeletal muscle by altering expression of adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) leads to the disruption of insulin signaling, and contributes to IR in humans (Badin et al. 2012).”
BackgroundDavegårdh, C., Broholm, C., Perfilyev, A., Henriksen, T. I., García-Calzón, S., Peijs, L., Hansen, N. S., Volkov, P., Kjøbsted, R., Wojtaszewski, J. F. P., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0792-x · Cited by 72
Carobbio, S., Rodriguez-Cuenca, S., & Vidal-Puig, A. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32834ad966 · Cited by 64
Intramyocellular lipid droplets and insulin sensitivity, the human perspective
Gemmink, A., Goodpaster, B. H., Schrauwen, P., & Hesselink, M. K. C. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.07.010 · Cited by 62
Changes in Cells Associated with Insulin Resistance
Szablewski, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042397 · Cited by 88
Huang, Y., Gao, S., Chen, J., Albrecht, E., Zhao, R., & Yang, X. (2017) · Oncotarget · doi:10.18632/oncotarget.14375 · Cited by 59
The G0/G1 Switch Gene 2 Is an Important Regulator of Hepatic Triglyceride Metabolism
Wang, Y., Zhang, Y., Qian, H., Lu, J., Zhang, Z., Min, X., Lang, M., Yang, H., Wang, N., & Zhang, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072315 · Cited by 60
“Reportedly, ATGL overexpression could promote DAG accumulation and disrupt insulin signaling and action in myotubes [37].”
BackgroundRegulation of skeletal muscle lipolysis and oxidative metabolism by the co-lipase CGI-58
Badin, P.-M., Loubière, C., Coonen, M., Louche, K., Tavernier, G., Bourlier, V., Mairal, A., Rustan, A. C., Smith, S. R., Langin, D., et al. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m019182 · Cited by 52
Self-citationTrites, M. J., & Clugston, R. D. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1151-z · Cited by 53
“resulted in a marked increase in DG, subsequent activation of PKC, and disrupted insulin signalling [48, 49].”
BackgroundLaurens, C., Louche, K., Sengenès, C., Coué, M., Langin, D., Moro, C., & Bourlier, V. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.193 · Cited by 57
“Myotubes were then exposed to new DMEM low glucose-GlutamaxTM supplemented with D[U14 C]glucose (1 μCi/ml, Perkinelmer) in the presence or absence of 100 nM of insulin for 3 h to study basal and insulin-mediated glycogen synthesis, as previously described (16).”
MethodSelf-citationBourlier, V., Saint-Laurent, C., Louche, K., Badin, P.-M., Thalamas, C., de Glisezinski, I., Langin, D., Sengenès, C., & Moro, C. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1727 · Cited by 60
“After 90-minute incubation in serum- and glucose-free medium, myotubes were exposed to DMEM supplemented with D[U-(14)C]glucose (1 Ci/mL; PerkinElmer) in the presence or absence of 100 nM of insulin (Umulin; Eli Lilly) for 3 hours to study basal and insulin-mediated glycogen synthesis as previously described (19).”
MethodSelf-citationInsulin Resistance and Environmental Pollutants: Experimental Evidence and Future Perspectives
Hectors, T. L. M., Vanparys, C., Gaal, L. F. V., Jorens, P. G., Covaci, A., & Blust, R. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.1307082 · Cited by 50
“…be performed in combination with these glucose production and glucose uptake assays are evaluation of insulin-stimulated glyco gen production (mainly in liver and skeletal muscle) (e.g., Badin et al. 2011; Gao et al. 2010) or insulininhibited lipolysis (adipose tissue) (e.g., Lee and Fried 2012).”
BackgroundBlasio, M. J. D., Gatford, K. L., Harland, M. L., Robinson, J. S., & Owens, J. A. (2012) · Endocrinology · doi:10.1210/en.2011-1955 · Cited by 48
Gómez‐Zorita, S., Fernández‐Quintela, A., Aguirre, L., Macarulla, M. T., Rimando, A. M., & Portillo, M. P. (2015) · Food & Function · doi:10.1039/c5fo00151j · Cited by 46
Triglyceride metabolism in exercising muscle
Watt, M. J., & Cheng, Y. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.06.015 · Cited by 54
Alsted, T. J., Ploug, T., Prats, C., Serup, A. K., Høeg, L., Schjerling, P., Holm, C., Zimmermann, R., Fledelius, C., Galbo, H., et al. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.260794 · Cited by 43
“TG hydrolase activity and decreased TG content in myotubes overexpressing ATGL (Badin et al. 2011).”
BackgroundHe, J., Zhang, J., Dong, L., Dang, X., Wang, L., Cheng, L., & Huang, Y. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s218487 · Cited by 43
Schweitzer, G. G., Collier, S. L., Chen, Z., McCommis, K. S., Pittman, S. K., Yoshino, J., Matkovich, S. J., Hsu, F., Chrast, R., Eaton, J. M., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201800361r · Cited by 39
Update on the synergistic effect of HSL and insulin in the treatment of metabolic disorders
Lan, Y., Lou, J., Lyu, W., & Zhang, B. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819877300 · Cited by 50
Dubé, J. J., Sitnick, M. T., Schoiswohl, G., Wills, R. C., Basantani, M. K., Cai, L., Pulinilkunnil, T., & Kershaw, E. E. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00530.2014 · Cited by 38
“Substantial evidence supports the importance of ATGL action in human skeletal muscle lipid metabolism (4, 7).”
BackgroundBakke, S. S., Moro, C., Nikolić, N., Hessvik, N. P., Badin, P.-M., Lauvhaug, L., Fredriksson, K., Hesselink, M. K. C., Boekschoten, M. V., Kersten, S., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.07.001 · Cited by 49
Self-citationLkb1 Deletion Promotes Ectopic Lipid Accumulation in Muscle Progenitor Cells and Mature Muscles
Shan, T., Zhang, P., Bi, P., & Kuang, S. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24831 · Cited by 39
Mason, R. R., Meex, R. C. R., Lee-Young, R., Canny, B. J., & Watt, M. J. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00082.2012 · Cited by 37
“Adipose triglyceride lipase (ATGL) is the predominant triacylglycerol lipase and is critical for efficient triacylglycerol lipolysis in all tissues assessed to date (2, 14, 29, 30, 36), including skeletal muscle (5, 16).”
BackgroundKase, E. T., Feng, Y. Z., Badin, P.-M., Bakke, S. S., Laurens, C., Coue, M., Langin, D., Gaster, M., Thoresen, G. H., Rustan, A. C., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.03.005 · Cited by 36
Self-citationGao, H., Feng, X., Li, Z.-M., Li, M., Gao, S., He, Y., Wang, J., Zeng, S.-Y., Liu, X., Huang, X., et al. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.11.009 · Cited by 35
Dotzert, M. S., Murray, M. R., McDonald, M. W., Olver, T. D., Velenosi, T. J., Hennop, A., Noble, E. G., Urquhart, B. L., & Melling, C. W. J. (2016) · Scientific Reports · doi:10.1038/srep26379 · Cited by 31
Intramyocellular fat storage in metabolic diseases
Laurens, C., & Moro, C. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0045 · Cited by 41
“ATGL activity is negatively associated with whole-body insulin sensitivity measured by a hyperinsulinemic-euglycemic clamp [81].”
BackgroundInfluentialSelf-citationZabielski, P., Blachnio-Zabielska, A., Lanza, I. R., Gopala, S., Manjunatha, S., Jakaitis, D. R., Persson, X.-M., Gransee, J., Klaus, K. A., Schimke, J. M., et al. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00610.2012 · Cited by 30
“Accumulation of intramyocellular ceramides (65, 66) and diacylglycerols (2, 31, 48) and their immediate precursors long-chain fatty acid-acylcoenzyme A (LCFa-CoA) (3, 21) are associated with decreased muscle glucose disposal and reduced insulin sensitivity in adults with type 2 diabetes (T2D).”
BackgroundOswal, N., Lizardo, K., Dhanyalayam, D., Ayyappan, J. P., Thangavel, H., Heysell, S. K., & Nagajyothi, J. F. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11061646 · Cited by 30
“Our data also suggest that an increased lipolysis/acute loss of adipocytes in adipose tissue and altered lipid metabolism in other organs including the lungs due to an increased accumulation of intracellular lipids may drive the pathogenesis of insulin resistance during Mtb infection [63,64].”
BackgroundMa, J., Karlsen, M. C., Chung, M., Jacques, P. F., Saltzman, E., Smith, C. E., Fox, C. S., & McKeown, N. M. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuv047 · Cited by 28
Tian, W., Cao, S., Guan, Y., Zhang, Z., Liu, Q., Ju, J., Xi, R., & Bai, R. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1516086 · Cited by 42
Whytock, K. L., Shepherd, S. O., Wagenmakers, A. J. M., & Strauss, J. A. (2018) · The Journal of Physiology · doi:10.1113/jp275502 · Cited by 31
“Moreover, overexpression of ATGL in human primary myotubes results in reduced TAG content and increased FA release and oxidation (Badin et al. 2011), whilst ATGL-knockout (KO) mice accumulate TAG in skeletal muscle (Haemmerle et al.”
BackgroundLaurens, C., Badin, P.-M., Louche, K., Mairal, A., Tavernier, G., Marette, A., Tremblay, A., Weisnagel, S. J., Joanisse, D. R., Langin, D., et al. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.04.004 · Cited by 32
“elevated expression and activity of ATGL causes insulin resistance in vitro in primary skeletal muscle cells [11].”
BackgroundSelf-citationBakke, S. S., Feng, Y., Nikolić, N., Kase, E. T., Moro, C., Stensrud, C., Damlien, L., Ludahl, M. O., Sandbu, R., Solheim, B. M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119556 · Cited by 30
“Reduced protein expression of the lipase HSL has previously been shown in obese insulinresistant subjects [24, 42], and increased protein levels of ATGL in both obese subjects with type 2 diabetes [22] and obese non-diabetic subjects [24].”
BackgroundSelf-citationKo, K., Woo, J., Bae, J. Y., Roh, H., Lee, Y. H., & Shin, K. O. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0730-8 · Cited by 28
“[29], this suggests that an imbalance in ATGL and HSL caused by decreased HSL can lead to metabolic disorders through the accumulation of lipotoxic molecules such as DAG and ceramide.”
InfluentialMason, R. R., Meex, R. C. R., Russell, A. P., Canny, B. J., & Watt, M. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103062 · Cited by 28
“with the development of insulin resistance [31,32] which has precipitated interest in understanding lipid droplet fatty acid fluxes”
BackgroundEffect of Weight Loss on Skeletal Muscle Bioactive Lipids in People With Obesity and Type 2 Diabetes
Petersen, M. C., Yoshino, M., Smith, G. I., Gaspar, R. C., Kahn, M., Samovski, D., Shulman, G. I., & Klein, S. (2024) · Diabetes · doi:10.2337/db24-0083 · Cited by 23
Galgani, J. E., Vásquez, K. Y., Watkins, G., Dupuy, A., Bertrand‐Michel, J., Levade, T., & Moro, C. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3111 · Cited by 27
Self-citationAguerd, O., Elhrech, H., Fessikh, M. E., Goh, K. W., Omari, N. E., Aanniz, T., & Bouyahya, A. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106705 · Cited by 24
Løvsletten, N. G., Rustan, A. C., Laurens, C., Thoresen, G. H., Moro, C., & Nikolić, N. (2019) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2019-0265 · Cited by 22
“It has been proposed by Badin et al. that an imbalance of ATGL relative to HSL may contribute to DAG accumulation and insulin resistance (Badin et al. 2011).”
BackgroundInfluentialSelf-citationLiu, C.-W., Huang, C., Hsu, C.-F., Li, T., Tsai, Y.-L., Lin, M., Tsai, H., Huang, S., Yang, Y., Hsieh, Y., et al. (2020) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2020-000381 · Cited by 19
Zhou, X., Ren, L., Yu, Z., Huang, X., Li, Y., & Wang, C. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.02.023 · Cited by 17
Hsu, M.-C., Wang, M., Jiang, Y.-F., Liu, H., Chen, Y., & Chiu, C. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0281-6 · Cited by 18
Barrett, J. S., Whytock, K. L., Strauss, J. A., Wagenmakers, A. J. M., & Shepherd, S. O. (2022) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2021-0631 · Cited by 18
Effect of Human Myotubes-Derived Media on Glucose-Stimulated Insulin Secretion
Mizgier, M. L., Cataldo, L. R., Gutierrez, J., Santos, J. L., Casas, M., Llanos, P., Contreras‐Ferrat, A. E., Moro, C., Bouzakri, K., & Galgani, J. E. (2017) · Journal of Diabetes Research · doi:10.1155/2017/1328573 · Cited by 16
“After incubation, glycogen synthesis was determined as described previously [22, 23].”
MethodSelf-citationEl-Shazly, S. A., Ahmed, M. M., Ibrahim, Z. S., & Refat, M. S. E.-D. (2015) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632015576036 · Cited by 11
The Buffering Role of HDL in Balancing the Effects of Hypercoagulable State in Type 2 Diabetes
Mard‐Soltani, M., Dayer, M. R., Shamshirga, A., Ali-Bahar, H., & Nasirbaghe, Z. (2012) · Journal of Applied Sciences · doi:10.3923/jas.2012.745.752 · Cited by 11
Mastrototaro, L., Apostolopoulou, M., Hartwig, S., Straßburger, K., Lipaeva, P., Trinks, N., Karusheva, Y., Gancheva, S., Trenkamp, S., Lehr, S., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105471 · Cited by 13
Wang, C., Ren, L., Chen, S., Zheng, H., Yang, Y., Gu, T., Li, Y., & Wang, C. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114072 · Cited by 11
UCHL1 Regulates Lipid and Perilipin 2 Level in Skeletal Muscle
Antony, R. M., Aby, K., Gao, H., Eichholz, M., Srinivasan, R., & Li, Y. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.855193 · Cited by 9
“, 2014), ATGL, HSL, and MAGL, the major lipases (Badin et al., 2011), suggesting that the reduced intramuscular lipid by UCHL1 smKO is unlikely due to the reduced fatty acid transport and increased lipolysis.”
BackgroundRemission of type 2 diabetes: position statement of the Italian society of diabetes (SID)
Capoccia, D., Leonetti, F., Natali, A., Tricò, D., Perrini, S., Sbraccia, P., Guglielmi, V., & On behalf of the Italian Society of Diabetes (SID) (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02317-x · Cited by 11
“…of toxic lipid intermediates such as ceramides and diacylglycerol, which interfere directly and indirectly with insulin signaling and insulin-regulated metabolic pathways [19], as well as through altered secretion of insulin-sensitizing lipid signaling molecules (e.g., fatty acid esters) [20, 21].”
BackgroundAbulmeaty, M. M. A., Almajwal, A. M., Al-Numair, K. S., Razak, S., Hasan, M. M., Fawzy, A., Farraj, A., Abudawood, M., & Aljuraiban, G. S. (2021) · Biology · doi:10.3390/biology10050413 · Cited by 9
“between HSL and ATGL affects diacylglycerol (DAG) accumulation in skeletal muscle and predispose to insulin resistance [37].”
BackgroundYang, N., Li, S., Liu, S., Lv, Y., Yu, L., Deng, Y., Li, H., Fang, M., Huo, Y., Li, W., et al. (2019) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001028 · Cited by 8
Zahran, N. H., Abu-Elsaoud, A. M., Mohamed, A. S., & Marie, O. (2025) · Biomedicines · doi:10.3390/biomedicines13092106 · Cited by 9
“This occurs due to the buildup of toxic lipid intermediates, including ceramides and diacylglycerols that interfere with the pathways of insulin signaling [71,72].”
Zhang, L., Ma, C., Huang, H., Li, D., Zhang, D., Wu, T., Chu, M., & Hu, F. (2024) · Food & Function · doi:10.1039/d4fo03761h · Cited by 6
Plin5: A potential therapeutic target for type 2 diabetes mellitus
Wei, M., Wang, Y., Zhang, Y., & Qiao, Y. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01680-1 · Cited by 7
“When the excess supply of fatty acids exceeds the energy demand of muscle cells, skeletal muscle [93] fails to mobilize triglyceride fatty acids and/ or increases triglyceride breakdown, leading to excessive intracellular lipid accumulation and insulin resistance [94, 95].”
Metadata
- Authors
- Badin, P.-M., Louche, K., Mairal, A., Liebisch, G., Schmitz, G., Rustan, A. C., Smith, S. R., Langin, D., & Moro, C.
- Affiliations
- Université Toulouse III - Paul Sabatier (FR)
- University of Regensburg (DE)
- University of Oslo (NO)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- INSERM, U1048, Obesity Research Laboratory, Institute of Metabolic and Cardiovascular Diseases (I2MC), Toulouse, France
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2011-05-21
- Volume
- 60
- Issue
- 6
- Pages
- 1734-1742
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3114384
- OpenAlex
- W2099224474
- Cited by
- 132
- References
- 52
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 8 · 2023: 4 · 2022: 6 · 2021: 5 · 2020: 6 · 2019: 8 · 2018: 9 · 2017: 10 · 2016: 8 · 2015: 17 · 2014: 6 · 2013: 20 · 2012: 14
- FWCI
- 6.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Funders
- Agence Nationale de la Recherche (ANR-09-JCJC-0019)
- National Institute on Aging (R01AG030226)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK020593, P30DK072476)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- insulin resistance, adipose triglyceride lipase, hormone-sensitive lipase, diacylglycerol accumulation, ceramide, triglycerides, lipolysis, insulin signaling, IRS-1, Akt activation, protein kinase C, glycogen synthesis, obesity, type 2 diabetes, myotubes
- MeSH terms
- Acyltransferases, Adult, Sterol Esterase, Chromatography, Gas, Diglycerides, Female, Humans, Insulin Resistance, Lipase, Male, Middle Aged, Mass Spectrometry, Triglycerides, Glucose Clamp Technique, Muscle, Skeletal, Spectrometry, Mass, Electrospray Ionization, Tandem Mass Spectrometry, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.